Degrees of progress shown above are figures calculated by SkyDrive based on the current status of discussions with the JCAB and progress in the JCAB assessment process. The General Certification Plan ...
X-TOLE2 met primary endpoint in both dose groups, including -53.2% median percent change (MPC) from baseline in monthly FOS frequency with 25 mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results